跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
NINLARO - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
NINLARO
Authorized
STANDARD
NINLARO
takeda canada inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
2a1820665bb180c0
Company
takeda canada inc
Type
Standard
Approval Details
Approval Id
2a1820665bb180c0
Drug Approval Canada Name
NINLARO
Product Name
NINLARO
Status
Marketed
Status Date
2016-09-21
Original Market Date
2016-09-21
Din
02456796
Drug Class
Human
Dosage Form
Capsule
Route Of Administration
Oral
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01XG03 IXAZOMIB
Atc Name
l 01 xg 03
Aig Number
0158410001
Company Name
takeda canada inc
Company Address
3800, 22 Adelaide Street West, Toronto, Ontario, Canada, M5H 4E3
Active Ingredients
IXAZOMIB (IXAZOMIB CITRATE)
2.3 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
2a1820665bb180c0
Type
Standard
Back to Health Canada Approvals